Literature DB >> 4038560

Glycerol dynamics in weight-losing cancer patients.

E Edén, S Edström, K Bennegárd, L Lindmark, K Lundholm.   

Abstract

This study was designed to show whether weight-losing cancer patients have an elevated glycerol turnover. Four groups of patients were examined: weight-losing cancer patients, weight-losing patients without cancer, cancer patients without weight loss, and weight-stable and well-nourished hospitalized control patients. Glycerol was infused intravenously at three different rates (200, 400, and 800 mumol/hr/kg body weight) after an overnight fast. This allowed measurement of clearance and plasma glycerol turnover. Weight-losing cancer patients (group 1) had an almost threefold higher glycerol turnover per kilogram of body weight compared with malnourished and well-nourished noncancer patients. However, both malnourished cancer and noncancer patients had an elevated glycerol turnover compared with well-nourished patients when glycerol turnover was related to whole body lipids. The results how that progressive clinical cancer is associated with an elevated plasma glycerol turnover, probably indicating an increased whole body lipolysis. This may explain the loss of body fat during the development of cancer cachexia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038560

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Thermic effect and substrate oxidation in response to intravenous nutrition in cancer patients who lose weight.

Authors:  L Lindmark; K Bennegård; E Edén; G Svaninger; M Ternell; K Lundholm
Journal:  Ann Surg       Date:  1986-12       Impact factor: 12.969

Review 2.  Metabolic alteration in patients with cancer: nutritional implications.

Authors:  Y Sakurai; S Klein
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

3.  Metabolic effects of nutritional support to cancer patients.

Authors:  L Lindmark; L Ekman
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

4.  Increased urinary excretion of cortisol and catecholami-NES in malnourished cancer patients.

Authors:  C Drott; G Svaninger; K Lundholm
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

5.  Whole-body lipolysis and triglyceride-fatty acid cycling in cachectic patients with esophageal cancer.

Authors:  S Klein; R R Wolfe
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  The oxidation of body fuel stores in cancer patients.

Authors:  D T Hansell; J W Davies; A Shenkin; H J Burns
Journal:  Ann Surg       Date:  1986-12       Impact factor: 12.969

Review 7.  Computational modeling of cancer cachexia.

Authors:  Kevin D Hall; Vickie E Baracos
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-05       Impact factor: 4.294

8.  Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.

Authors:  J S Falconer; K C Fearon; C E Plester; J A Ross; D C Carter
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

9.  Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients.

Authors:  P Groundwater; S A Beck; C Barton; C Adamson; I N Ferrier; M J Tisdale
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

Review 10.  Pharmacokinetics of drugs in cachectic patients: a systematic review.

Authors:  Katja Trobec; Mojca Kerec Kos; Stephan von Haehling; Jochen Springer; Stefan D Anker; Mitja Lainscak
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.